Announcement on Voluntary Disclosure of Obtaining EU Approval for Shortening Dual Antiplatelet Therapy Duration to One Month for All Patient Populations Using the Company’s Coronary Stent Products

About this update from Sino Medical Sciences Technology Inc. Class A

Announcement on Voluntary Disclosure of Obtaining EU Approval for Shortening Dual Antiplatelet Therapy Duration to One Month for All Patient Populations Using the Company’s Coronary Stent Products The abstract is for reference only. Please refer to the full text of the announcement on the very day. Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Sino Medical Sciences Technology Inc. Class A